For decades, people from all over the world have trusted their hearts to the Smidt Heart Institute at Cedars-Sinai.

A global leader in heart transplant, women’s heart disease, targeted therapies and a suite of minimally invasive procedures, the Smidt Heart Institute has received worldwide acclaim for consistently achieving the best outcomes for people with heart disease.

Our specialized care team treats the full spectrum of cardiovascular disease, including vascular abnormalities, congenital heart disease, heart failure, coronary artery disease, valve dysfunction and rhythm disorders. Working seamlessly with clinicians, our investigators break new ground with lifesaving research efforts that effect change in California and around the globe.

Whether patients travel thousands of miles for care or live blocks away from Cedars-Sinai, the Smidt Heart Institute’s focus on technology and innovation provides transformational care to all patients.

Explore the Report

SMIDT HEART INSTITUTE

Executive Director:
Eduardo Marbán, MD, PhD
Mark Siegel Family Foundation Distinguished Chair
Professor of Cardiology and Biomedical Sciences

DEPARTMENT OF CARDIOLOGY

Chair: Christine M. Albert, MD, MPH
Lee and Harold Kapelovitz Distinguished Chair in Cardiology
Professor of Cardiology

DEPARTMENT OF CARDIAC SURGERY

Chair: Joanna Chikwe, MD
Irina and George Schaeffer Distinguished Chair
in Cardiac Surgery in honor of Alfredo Trento, MD
Professor of Cardiac Surgery

SMIDT HEART INSTITUTE VASCULAR PROGRAM

Associate Director of Vascular Therapeutics: Ali Azizzadeh, MD
Director, Division of Vascular Surgery
Professor of Surgery

Points of Pride

Rankings

#1
IN CALIFORNIA (highest U.S. News ranking in the region)

#2
IN THE NATION

Outcomes

30-Day Risk-Adjusted Mortality
July-Dec. 2019 and July 2020-June 2022

HEART ATTACK

6.9% CEDARS-SINAI

11.8% NATIONAL

HEART FAILURE

9.2% CEDARS-SINAI

12.6% NATIONAL

Highlights

CARDIAC SURGERY

The highest quality rating from the Society of Thoracic Surgeons

No. 1 Mitral Valve Repair Center in the western U.S.

>1,500 robotic mitral valve repairs, with near 100% success rate

>20 years of Ross procedures, with zero early mortality

INTERVENTIONAL CARDIOLOGY

World-renowned experts in all structural heart procedures

>6,000 TAVRs performed to date

1,885 MitraClips performed to date

ADVANCED HEART DISEASE: HEART FAILURE

The most advanced care for complex heart failure, with some of the nation’s best outcomes

HEART TRANSPLANT AND MECHANICAL CIRCULATORY SUPPORT

One of the largest heart transplant programs in the U.S.

>1,600 transplants to date

132 durable and temporary mechanical circulatory support devices placed in FY23

LUNG TRANSPLANT

Performed the first robotically assisted double-lung transplant

State-of-the-art care, using minimally invasive techniques for 57% of lung transplants in FY23

ELECTROPHYSIOLOGY

PIONEER diagnostic tools and SPECIALIZE in the identification and treatment of heart disease in women

National leaders in cardiac arrest prevention and research

Leading the integration of artificial intelligence into advanced cardiac care and imaging

CONGENITAL HEART

Seamless, comprehensive congenital cardiac care, from conception to advanced age

First-in-human novel percutaneous pulmonary valve replacement

Zero 30-day Surgical mortality for 190 consecutive cases

AORTIC DISEASES

Experts in complex treatment, including open and endovascular aortic repair

Recognized by the Marfan Foundation for expertise in comprehensive genetic aortic and vascular care

VASCULAR DISORDERS

Major destination for minimally invasive and complex open aortic surgery

Advanced, personalized care using approved and investigational devices

Cedars Sinai

The Susanne and Ervin Bard Pavilion at the Smidt Heart Institute at Cedars-Sinai in the heart of Los Angeles

Patient journeys—the case, the care, the conclusion

After consulting with a regional specialist, Betty Ward-Cooper (74) was disappointed to hear she should expect open-heart surgery for her symptomatic mitral valve regurgitation. She began researching the latest techniques in mitral valve repair and consulted the Smidt Heart Institute’s surgeons for their expertise in minimally invasive solutions.

Matt Philbrook (61) presented with restrictive cardiomyopathy and chest inflammation due to radiation treatment for Hodgkin lymphoma in the 1980s. A heart valve replacement done locally in 2019 began to fail, and Matt’s Idaho cardiologist told him he would require a heart transplant from a center with advanced capabilities.

Tim Fitzgerald (37) was referred to the Smidt Heart Institute after an attempt to address congenital aortic valve stenosis at another hospital failed due to a hostile chest cavity.

Claudia Huerta (44) experienced high resting heart rates, fatigue and dizziness, which prompted her to schedule a visit with her primary care physician. Follow-up monitoring with Cedars-Sinai resulted in a diagnosis of hereditary paroxysmal atrial fibrillation (AFib)/flutter (13% burden).

Contents

Choose a topic to learn more.

Referral Resources

If you have a patient you would like to refer to one of our programs, please contact us at 310-423-3300 or heartinstitute@cshs.org. Our physicians will partner with you to understand and address the unique needs of your patient.

2024 Heart Annual Report